PLENVU 9 G — DIN 02550938
SODIUM SULFATE ANHYDROUS : 9 G SODIUM ASCORBATE : 48.11 G POTASSIUM CHLORIDE : 2.2 G POLYETHYLENE GLYCOL 3350 : 140 G SODIUM CHLORIDE : 5.2 G ASCORBIC ACID : 7.54 G · BAUSCH HEALTH, CANADA INC. · KIT ; POWDER FOR SOLUTION · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is PLENVU?
PLENVU 9 G contains SODIUM SULFATE ANHYDROUS : 9 G SODIUM ASCORBATE : 48.11 G POTASSIUM CHLORIDE : 2.2 G POLYETHYLENE GLYCOL 3350 : 140 G SODIUM CHLORIDE : 5.2 G ASCORBIC ACID : 7.54 G. It is listed in the Health Canada Drug Product Database under DIN 02550938, held by BAUSCH HEALTH, CANADA INC., supplied as KIT ; POWDER FOR SOLUTION for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 30-Jul-2026. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Macrogol, Combinations in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
4 holders have a Canadian DIN containing Macrogol, Combinations, across 8 DINs, of which 3 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| JAMP PHARMA CORPORATION | 4 | 1 | JAMP-ELECTROPEG, JAMP-ELECTROPEG WITH FLAVOUR PACKET, JAMPLYTE | Sourceable in Canada |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 2 | 1 | COLYTE, KLEAN-PREP | Sourceable in Canada |
| ARALEZ PHARMACEUTICALS CANADA INC | 1 | 1 | MOVIPREP | Sourceable in Canada |
| BAUSCH HEALTH, CANADA INC. | 1 | 0 | PLENVU | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 9 G |
|---|---|
| Dosage form | KIT ; POWDER FOR SOLUTION |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Macrogol, Combinations |
|---|---|
| ATC code | A06AD65 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02550938 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2550938 |
| Brand name | PLENVU |
| Generic / active ingredient | SODIUM SULFATE ANHYDROUS : 9 G SODIUM ASCORBATE : 48.11 G POTASSIUM CHLORIDE : 2.2 G POLYETHYLENE GLYCOL 3350 : 140 G SODIUM CHLORIDE : 5.2 G ASCORBIC ACID : 7.54 G |
| Market authorization holder | BAUSCH HEALTH, CANADA INC. |
| Health Canada schedule | Ethical |
| ATC code | A06AD65 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A06AD |
| Current status | CANCELLED PRE MARKET |
| Status date | 30-Jul-2026 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 8 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| COLYTE | 10.65 MG | POWDER FOR SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | 00677442 |
| JAMPLYTE | 22.96 G / 280 G | POWDER | JAMP PHARMA CORPORATION | MARKETED | 02378329 |
| MOVIPREP | 2.691 G | POWDER FOR SOLUTION | ARALEZ PHARMACEUTICALS CANADA INC | MARKETED | 02359499 |
| JAMP-ELECTROPEG | 2.97 G | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | APPROVED | 02406780 |
| JAMP-ELECTROPEG WITH FLAVOUR PACKET | 2.97 G | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | APPROVED | 02406799 |
| JAMPLYTE | 0.76 G | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | APPROVED | 02368234 |
| KLEAN-PREP | 1.68 G | POWDER FOR SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | 02147793 |
2 · Same class — other molecules in ATC A06AD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Macrogol | CLARILAX · CLEARLAX · COLAXOR · COMFILAX · +17 more | 22 | 12 | Yes |
| Lactulose | CEPHULAC SYR 667MG/ML · CHRONULAC SYR · CHRONULAC SYR 667MG/ML · COMALOSE R SIROP 10GM/15ML · +20 more | 28 | 5 | Yes |
| Macrogol, Combinations | COLYTE · JAMP-ELECTROPEG · JAMP-ELECTROPEG WITH FLAVOUR PACKET · JAMPLYTE · +3 more | 8 | 3 | Yes |
| Mineral Salts In Combination | CEO-TWO BOWEL EVACUANT SUPPOSITORIES · EAU PURGATIVE RIGA · ELECTROPEG SOLUTION · GOLYTELY GI LAVAGE SOLUTION · +8 more | 13 | 1 | Yes |
| Magnesium Sulphate | EPSOM SALT PWS 100% · EPSOM SALTS · SEL D EPSOM | 6 | 0 | Not in Canada |
| Magnesium Sulphate, Combinations | AGOBYL GRANULE · AGOBYL LIQUIDE · FORMULE 1705 - LIQ | 3 | 0 | Not in Canada |
| Sodium Phosphate | EURO-PHOSPHATES SOLUTION · PHOSPHO-SODA BUFFERED SALINE LAXATIVE · PMS-PHOSPHATES SOLUTION | 3 | 0 | Not in Canada |
| Sorbitol | SORBITOL ROUGIER PWS 5GM | 1 | 0 | Not in Canada |
| Sodium Tartrate | LIMONADE RODECA | 1 | 0 | Not in Canada |
| Magnesium Oxide | MAGNESIUM CITRATE ORAL SOLUTION | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A06AB | Bisacodyl · Bisacodyl, Combinations · Cascara · Cascara, Combinations · Castor Oil · +9 more | 239 | 25 |
| A06AA | Docusate Sodium · Docusate Sodium, Combinations · Liquid Paraffin · Liquid Paraffin, Combinations | 144 | 22 |
| A06AX | Glycerol · Linaclotide · Lubiprostone · Other Laxatives · Plecanatide · +2 more | 30 | 14 |
| A06AH | Methylnaltrexone Bromide · Naloxegol | 5 | 3 |
| A06AG | Bisacodyl · Combinations · Docusate Sodium, Incl Combinations · Sodium Phosphate | 7 | 1 |
| A06AC | Ispaghula (Psylla Seeds) · Ispaghula, Combinations · Linseed · Methylcellulose · Polycarbophil Calcium · +2 more | 79 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.